Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

ONS 44th Annual Congress /
Checkpoint inhibitor induced Guillain-Barré syndrome

11th - 14th Apr 2019

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 08.05.19
Views: 263
Rating:

Jessica Edwards - The Ohio State University James Cancer Hospital, Ohio, USA

Jessica Edwards speaks to ecancer at ONS 2019 about checkpoint inhibitor induced Guillain-Barre syndrome.

She explains that Guillain-Barre syndrome is a neurological symptom that can cause paralysis amongst other symptoms.

Jessica explains that it is important for oncology nurses to be aware of rare side effects that their patients can experience as a result of their treatments.

Previous conferences: highlights



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation